Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 19.83 USD -1.05%
Market Cap: 1.4B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Nurix Therapeutics Inc

Current Assets 456m
Cash & Short-Term Investments 448.1m
Other Current Assets 8m
Non-Current Assets 57.6m
Long-Term Investments 9.5m
PP&E 44.2m
Other Non-Current Assets 3.9m
Current Liabilities 86.3m
Accounts Payable 3.9m
Accrued Liabilities 34.4m
Other Current Liabilities 48m
Non-Current Liabilities 50.4m
Other Non-Current Liabilities 50.4m

Balance Sheet
Nurix Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Nov-2018 Nov-2019 Nov-2020 Nov-2021 Nov-2022 Nov-2023
Assets
Cash & Cash Equivalents
25
35
119
80
65
55
Cash Equivalents
25
35
119
80
65
55
Short-Term Investments
13
3
162
215
245
233
Total Receivables
0
0
11
6
0
0
Accounts Receivables
0
0
8
6
0
0
Other Receivables
0
0
4
0
0
0
Other Current Assets
2
2
6
10
9
8
Total Current Assets
41
39
298
311
318
296
PP&E Net
4
4
7
25
30
48
PP&E Gross
4
4
7
25
30
48
Accumulated Depreciation
9
11
13
15
20
26
Long-Term Investments
0
1
91
137
64
7
Other Long-Term Assets
0
0
0
3
5
5
Total Assets
45
N/A
44
-3%
396
+801%
477
+20%
417
-13%
356
-15%
Liabilities
Accounts Payable
1
2
3
7
5
6
Accrued Liabilities
3
5
8
18
28
32
Short-Term Debt
0
0
0
0
0
0
Other Current Liabilities
28
10
33
41
38
48
Total Current Liabilities
33
16
45
66
71
87
Long-Term Debt
0
0
0
0
0
0
Other Liabilities
1
37
62
68
42
68
Total Liabilities
34
N/A
54
+58%
106
+98%
135
+27%
113
-16%
155
+37%
Equity
Common Stock
48
48
0
0
0
0
Retained Earnings
39
61
104
221
401
545
Additional Paid In Capital
2
3
394
564
709
746
Other Equity
0
0
0
1
4
1
Total Equity
11
N/A
10
N/A
290
N/A
342
+18%
304
-11%
200
-34%
Total Liabilities & Equity
45
N/A
44
-3%
396
+801%
477
+20%
417
-13%
356
-15%
Shares Outstanding
Common Shares Outstanding
11
11
39
45
47
49

See Also

Discover More